{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T05:28:42Z","timestamp":1780637322078,"version":"3.54.1"},"reference-count":56,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100001003","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001003","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.xphs.2025.104126","type":"journal-article","created":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T07:58:05Z","timestamp":1765353485000},"page":"104126","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Specific polysorbate fingerprints of CHO hydrolases and implications for indirect assays"],"prefix":"10.1016","volume":"115","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-4101-5751","authenticated-orcid":false,"given":"Melanie","family":"Maier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viktor","family":"Gross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6905-5283","authenticated-orcid":false,"given":"Linus","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3619-6821","authenticated-orcid":false,"given":"Simon","family":"Kluters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joey","family":"Studts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3586-4215","authenticated-orcid":false,"given":"Matthias","family":"Franzreb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9512-9533","authenticated-orcid":false,"given":"Patrick","family":"Garidel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xphs.2025.104126_bib0001","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2024.1490276","article-title":"Polysorbates degrading enzymes in biotherapeutics \u2013 a current status and future perspectives","volume":"12","author":"Felix","year":"2025","journal-title":"Front Bioeng Biotechnol"},{"issue":"Pt A","key":"10.1016\/j.xphs.2025.104126_bib0002","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ejpb.2015.09.016","article-title":"Key interactions of surfactants in therapeutic protein formulations: A review","volume":"97","author":"Khan","year":"2015","journal-title":"Eur J Pharm Biopharm"},{"issue":"11","key":"10.1016\/j.xphs.2025.104126_bib0003","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.1016\/j.xphs.2022.08.021","article-title":"Industry Perspective on the Use and Characterization of Polysorbates for Biopharmaceutical Products Part 2: Survey Report on Control Strategy Preparing for the Future","volume":"111","author":"Wuchner","year":"2022","journal-title":"J Pharm Sci"},{"issue":"11","key":"10.1016\/j.xphs.2025.104126_bib0004","doi-asserted-by":"crossref","first-page":"3792","DOI":"10.1021\/acs.molpharmaceut.5b00310","article-title":"Understanding Particle Formation: Solubility of Free Fatty Acids as Polysorbate 20 Degradation Byproducts in Therapeutic Monoclonal Antibody Formulations","volume":"12","author":"Doshi","year":"2015","journal-title":"Mol Pharm"},{"issue":"9","key":"10.1016\/j.xphs.2025.104126_bib0005","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1007\/s11095-015-1670-x","article-title":"Identification of Subvisible Particles in Biopharmaceutical Formulations Using Raman Spectroscopy Provides Insight into Polysorbate 20 Degradation Pathway","volume":"32","author":"Saggu","year":"2015","journal-title":"Pharm Res"},{"key":"10.1016\/j.xphs.2025.104126_bib0006","article-title":"Fatty acid solubility determination in biopharmaceutical formulations containing polysorbate 20 using a design of experiments approach","volume":"111","author":"Gro\u00df","year":"2025","journal-title":"J Drug Deliv Sci Technol"},{"issue":"1-2","key":"10.1016\/j.xphs.2025.104126_bib0007","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.ijpharm.2018.10.008","article-title":"Polysorbate degradation in biotherapeutic formulations: Identification and discussion of current root causes","volume":"552","author":"Dwivedi","year":"2018","journal-title":"Int J Pharm"},{"issue":"8","key":"10.1016\/j.xphs.2025.104126_bib0008","doi-asserted-by":"crossref","first-page":"2924","DOI":"10.1002\/jps.21190","article-title":"Polysorbates 20 and 80 used in the formulation of protein biotherapeutics: Structure and degradation pathways","volume":"97","author":"Kerwin","year":"2008","journal-title":"J Pharm Sci"},{"issue":"5","key":"10.1016\/j.xphs.2025.104126_bib0009","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1007\/s11095-011-0385-x","article-title":"The Degradation of Polysorbates 20 and 80 and its Potential Impact on the Stability of Biotherapeutics","volume":"28","author":"Kishore","year":"2011","journal-title":"Pharm Res"},{"key":"10.1016\/j.xphs.2025.104126_bib0010","article-title":"Comprehensive investigation of factors influencing the degradation of polysorbate 20: Insights into mechanisms and interactions using a design of experiments approach","volume":"101","author":"Schultz-Fademrecht","year":"2024","journal-title":"J Drug Deliv Sci Technol"},{"issue":"6","key":"10.1016\/j.xphs.2025.104126_bib0011","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.biologicals.2015.07.011","article-title":"Subvisible (2\u2013100 \u03bcm) particle analysis during biotherapeutic drug product development: Part 2, experience with the application of subvisible particle analysis","volume":"43","author":"Corvari","year":"2015","journal-title":"Biologicals"},{"key":"10.1016\/j.xphs.2025.104126_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.xphs.2023.01.003","article-title":"Characterization of Recombinantly-Expressed Hydrolytic Enzymes from Chinese Hamster Ovary Cells: Identification of Host Cell Proteins that Degrade Polysorbate","author":"Kovner","year":"2023","journal-title":"J Pharm Sci"},{"issue":"1","key":"10.1016\/j.xphs.2025.104126_bib0013","doi-asserted-by":"crossref","DOI":"10.1080\/19420862.2024.2375798","article-title":"Illuminating a biologics development challenge: systematic characterization of CHO cell-derived hydrolases identified in monoclonal antibody formulations","volume":"16","author":"Maier","year":"2024","journal-title":"mAbs"},{"issue":"11","key":"10.1016\/j.xphs.2025.104126_bib0014","doi-asserted-by":"crossref","first-page":"3558","DOI":"10.1016\/j.xphs.2021.06.033","article-title":"Identification and Characterization of Polysorbate-Degrading Enzymes in a Monoclonal Antibody Formulation","volume":"110","author":"Graf","year":"2021","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.xphs.2025.104126_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.xphs.2024.05.013","article-title":"Identification of Acyl-Protein Thioesterase-1 as a Polysorbate-degrading Host Cell Protein in a Monoclonal Antibody Formulation Using Activity-based Protein Profiling","author":"\u0160prager","year":"2024","journal-title":"J Pharm Sci."},{"key":"10.1016\/j.xphs.2025.104126_bib0016","article-title":"Investigating pH Effects on Enzymes Catalyzing Polysorbate Degradation by Activity-Based Protein Profiling","author":"Dehghani","year":"2023","journal-title":"J Pharm Sci."},{"issue":"12","key":"10.1016\/j.xphs.2025.104126_bib0017","doi-asserted-by":"crossref","first-page":"3866","DOI":"10.1016\/j.xphs.2021.09.001","article-title":"Degradation of Polysorbate 20 by Sialate O-Acetylesterase in Monoclonal Antibody Formulations","volume":"110","author":"Zhang","year":"2021","journal-title":"J Pharm Sci"},{"issue":"5","key":"10.1016\/j.xphs.2025.104126_bib0018","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1016\/j.xphs.2016.02.022","article-title":"Polysorbates 20 and 80 Degradation by Group XV Lysosomal Phospholipase A2 Isomer X1 in Monoclonal Antibody Formulations","volume":"105","author":"Hall","year":"2016","journal-title":"J Pharm Sci"},{"issue":"23","key":"10.1016\/j.xphs.2025.104126_bib0019","doi-asserted-by":"crossref","first-page":"8161","DOI":"10.1021\/acs.analchem.1c00042","article-title":"Profiling Active Enzymes for Polysorbate Degradation in Biotherapeutics by Activity-Based Protein Profiling","volume":"93","author":"Li","year":"2021","journal-title":"Anal Chem"},{"issue":"4","key":"10.1016\/j.xphs.2025.104126_bib0020","doi-asserted-by":"crossref","first-page":"332","DOI":"10.5731\/pdajpst.2015.005942","article-title":"Hydrolysis of Polysorbate 20 and 80 by a Range of Carboxylester Hydrolases","volume":"70","author":"McShan","year":"2016","journal-title":"Pda J Pharm Sci Tech"},{"issue":"1","key":"10.1016\/j.xphs.2025.104126_bib0021","article-title":"The measurement and control of high-risk host cell proteins for polysorbate degradation in biologics formulation","volume":"5","author":"Li","year":"2022","journal-title":"Antib Ther"},{"issue":"5","key":"10.1016\/j.xphs.2025.104126_bib0022","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1002\/bit.26237","article-title":"Knockout of a difficult-to-remove CHO host cell protein, lipoprotein lipase, for improved polysorbate stability in monoclonal antibody formulations","volume":"114","author":"Chiu","year":"2017","journal-title":"Biotechnol Bioeng"},{"issue":"1","key":"10.1016\/j.xphs.2025.104126_bib0023","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/bit.28563","article-title":"Multi-lipase gene knockdown in Chinese hamster ovary cells using artificial microRNAs to reduce host cell protein mediated polysorbate degradation","volume":"121","author":"Wei\u00df","year":"2024","journal-title":"Biotechnol Bioeng"},{"key":"10.1016\/j.xphs.2025.104126_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.tibtech.2025.04.016","article-title":"Without a trace: multiple knockout of CHO host cell hydrolases to prevent polysorbate degradation in biologics","author":"Wei\u00df","year":"2025","journal-title":"Trends Biotechnol."},{"issue":"9","key":"10.1016\/j.xphs.2025.104126_bib0025","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.1016\/j.xphs.2021.05.012","article-title":"Polysorbate degradation and particle formation in a high concentration mAb: formulation strategies to minimize effect of enzymatic polysorbate degradation","volume":"110","author":"Roy","year":"2021","journal-title":"J Pharm Sci"},{"issue":"1","key":"10.1016\/j.xphs.2025.104126_bib0026","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s11095-021-03160-3","article-title":"Identification of the specific causes of polysorbate 20 degradation in monoclonal antibody formulations containing multiple lipases","volume":"39","author":"Zhang","year":"2022","journal-title":"Pharmaceut Res"},{"issue":"12","key":"10.1016\/j.xphs.2025.104126_bib0027","doi-asserted-by":"crossref","first-page":"3869","DOI":"10.1002\/bit.28844","article-title":"Buffer system improves the removal of host cell protein impurities in monoclonal antibody purification","volume":"121","author":"Lakatos","year":"2024","journal-title":"Biotechnol Bioeng"},{"issue":"10","key":"10.1016\/j.xphs.2025.104126_bib0028","doi-asserted-by":"crossref","first-page":"3181","DOI":"10.1002\/bit.28767","article-title":"Tailoring polishing steps for effective removal of polysorbate-degrading host cell proteins in antibody purification","volume":"121","author":"Maier","year":"2024","journal-title":"Biotechnol Bioeng"},{"issue":"4","key":"10.1016\/j.xphs.2025.104126_bib0029","doi-asserted-by":"crossref","first-page":"e2983","DOI":"10.1002\/btpr.2983","article-title":"A novel approach to evaluate ELISA antibody coverage of host cell proteins\u2014combining ELISA-based immunocapture and mass spectrometry","volume":"36","author":"Pilely","year":"2020","journal-title":"Biotechnol Prog"},{"issue":"2","key":"10.1016\/j.xphs.2025.104126_bib0030","doi-asserted-by":"crossref","first-page":"e3986","DOI":"10.1002\/cbf.3986","article-title":"Establishment and evaluation of detection methods for process-specific residual host cell protein and residual host cell DNA in biological preparation","volume":"42","author":"Tian","year":"2024","journal-title":"Cell Biochem Funct"},{"issue":"1","key":"10.1016\/j.xphs.2025.104126_bib0031","doi-asserted-by":"crossref","DOI":"10.1080\/19420862.2023.2213365","article-title":"Technical advancement and practical considerations of LC-MS\/MS-based methods for host cell protein identification and quantitation to support process development","volume":"15","author":"Guo","year":"2023","journal-title":"mAbs"},{"issue":"3","key":"10.1016\/j.xphs.2025.104126_bib0032","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jprot.2008.05.002","article-title":"The ProteoMiner in the proteomic arena: A non-depleting tool for discovering low-abundance species","volume":"71","author":"Boschetti","year":"2008","journal-title":"J Proteom"},{"issue":"15","key":"10.1016\/j.xphs.2025.104126_bib0033","doi-asserted-by":"crossref","first-page":"10327","DOI":"10.1021\/acs.analchem.0c00360","article-title":"Enhancing Host-Cell Protein Detection in Protein Therapeutics Using HILIC Enrichment and Proteomic Analysis","volume":"92","author":"Wang","year":"2020","journal-title":"Anal Chem"},{"key":"10.1016\/j.xphs.2025.104126_bib0034","article-title":"Identification and quantification of a problematic host cell protein to support therapeutic protein development","author":"SY","year":"2022","journal-title":"J Pharm Sci."},{"key":"10.1016\/j.xphs.2025.104126_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.ab.2022.114901","article-title":"Ultrasensitive method for profiling host cell proteins by coupling limited digestion to ProteoMiner technology","volume":"657","author":"Zhang","year":"2022","journal-title":"Anal Biochem"},{"issue":"9","key":"10.1016\/j.xphs.2025.104126_bib0036","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.1016\/j.xphs.2020.05.028","article-title":"Putative Phospholipase B-Like 2 is Not Responsible for Polysorbate Degradation in Monoclonal Antibody Drug Products","volume":"109","author":"Zhang","year":"2020","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.xphs.2025.104126_bib0037","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2021.105980","article-title":"Assessing the polysorbate degradation fingerprints and kinetics of lipases \u2013 how the activity of polysorbate degrading hydrolases is influenced by the assay and assay conditions","volume":"166","author":"Gl\u00fccklich","year":"2021","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.xphs.2025.104126_bib0038","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jpba.2016.09.033","article-title":"Impact of mono- and poly-ester fractions on polysorbate quantitation using mixed-mode HPLC-CAD\/ELSD and the fluorescence micelle assay","volume":"132","author":"Lippold","year":"2017","journal-title":"J Pharm Biomed Anal"},{"key":"10.1016\/j.xphs.2025.104126_bib0039","article-title":"Oxidation of polysorbates - An underestimated degradation pathway?","volume":"6","author":"Weber","year":"2023","journal-title":"Int J Pharm: X"},{"issue":"2","key":"10.1016\/j.xphs.2025.104126_bib0040","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/0003-2697(86)90406-9","article-title":"Determination of the critical micelle concentration of surfactants using the fluorescent probe N-phenyl-1-naphthylamine","volume":"152","author":"Brito","year":"1986","journal-title":"Anal Biochem"},{"key":"10.1016\/j.xphs.2025.104126_bib0041","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.122660","article-title":"Existence of a superior polysorbate fraction in respect to protein stabilization and particle formation?","volume":"635","author":"Diederichs","year":"2023","journal-title":"Int J Pharm"},{"issue":"6","key":"10.1016\/j.xphs.2025.104126_bib0042","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/s11095-020-02812-0","article-title":"Measuring Lipolytic Activity to Support Process Improvements to Manage Lipase-Mediated Polysorbate Degradation","volume":"37","author":"Jahn","year":"2020","journal-title":"Pharmaceut Res"},{"issue":"3","key":"10.1016\/j.xphs.2025.104126_bib0043","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s11095-021-03011-1","article-title":"High-Throughput, Fluorescence-Based Esterase Activity Assay for Assessing Polysorbate Degradation Risk during Biopharmaceutical Development","volume":"38","author":"Bhargava","year":"2021","journal-title":"Pharm Res"},{"key":"10.1016\/j.xphs.2025.104126_bib0044","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2021.122717","article-title":"Hydrolytic polysorbate 20 degradation \u2013 Sensitive detection of free fatty acids in biopharmaceuticals via UPLC-QDa analytics with isolator column","volume":"1174","author":"Evers","year":"2021","journal-title":"J Chromatogr B"},{"key":"10.1016\/j.xphs.2025.104126_bib0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2020.122287","article-title":"Development and validation of a selective marker-based quantification of polysorbate 20 in biopharmaceutical formulations using UPLC QDa detection","volume":"1157","author":"Evers","year":"2020","journal-title":"J Chromatogr B"},{"key":"10.1016\/j.xphs.2025.104126_bib0046","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2023.123955","article-title":"All-in-one stability indicating polysorbate 20 degradation root-cause analytics via UPLC-QDa","volume":"1232","author":"Carle","year":"2024","journal-title":"J Chromatogr B"},{"key":"10.1016\/j.xphs.2025.104126_bib0047","article-title":"Extraction of the Polysorbate 20 and 80 Fingerprint via Generative Modelling","volume":"10","author":"Roelants","year":"2025","journal-title":"Int J Pharma: X"},{"issue":"7","key":"10.1016\/j.xphs.2025.104126_bib0048","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1016\/j.xphs.2021.03.017","article-title":"A review of Formulations of Commercially Available Antibodies","volume":"110","author":"Strickley","year":"2021","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.xphs.2025.104126_bib0049","article-title":"Enzymatic degradation pattern of polysorbate 20 impacts interfacial properties of monoclonal antibody formulations","author":"Gregoritza","year":"2023","journal-title":"Eur J Pharm Biopharm."},{"issue":"1","key":"10.1016\/j.xphs.2025.104126_bib0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jps.20727","article-title":"Antibody structure, instability, and formulation","volume":"96","author":"Wang","year":"2007","journal-title":"J Pharm Sci"},{"issue":"6","key":"10.1016\/j.xphs.2025.104126_bib0051","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1002\/jps.20079","article-title":"Challenges in the development of high protein concentration formulations","volume":"93","author":"Shire","year":"2004","journal-title":"J Pharm Sci"},{"issue":"9","key":"10.1016\/j.xphs.2025.104126_bib0052","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1002\/bit.25628","article-title":"The future of host cell protein (HCP) identification during process development and manufacturing linked to a risk-based management for their control","volume":"112","author":"Bracewell","year":"2015","journal-title":"Biotechnol Bioeng"},{"issue":"8","key":"10.1016\/j.xphs.2025.104126_bib0053","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.1021\/acs.molpharmaceut.1c00406","article-title":"Complex Micellization Behavior of the Polysorbates Tween 20 and Tween 80","volume":"18","author":"Knoch","year":"2021","journal-title":"Mol Pharm"},{"issue":"7","key":"10.1016\/j.xphs.2025.104126_bib0054","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1016\/j.xphs.2017.03.001","article-title":"Trends on Analytical Characterization of Polysorbates and Their Degradation Products in Biopharmaceutical Formulations","volume":"106","author":"Martos","year":"2017","journal-title":"J Pharm Sci"},{"issue":"7","key":"10.1016\/j.xphs.2025.104126_bib0055","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1021\/acs.molpharmaceut.0c00093","article-title":"Characterization of Polysorbate Ester Fractions and Implications in Protein Drug Product Stability","volume":"17","author":"Tomlinson","year":"2020","journal-title":"Mol Pharm"},{"issue":"10","key":"10.1016\/j.xphs.2025.104126_bib0056","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.1016\/j.xphs.2020.06.030","article-title":"Evaluation of Super RefinedTM Polysorbate 20 With Respect to Polysorbate Degradation, Particle Formation and Protein Stability","volume":"109","author":"Doshi","year":"2020","journal-title":"J Pharm Sci"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354925005805?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354925005805?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T05:36:33Z","timestamp":1771392993000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354925005805"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":56,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S0022354925005805"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2025.104126","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Specific polysorbate fingerprints of CHO hydrolases and implications for indirect assays","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2025.104126","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc. on behalf of American Pharmacists Association.","name":"copyright","label":"Copyright"}],"article-number":"104126"}}